Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients
2021 ◽
2021 ◽
2020 ◽
Vol 45
(1)
◽
pp. 19-31
◽
2018 ◽
2019 ◽
Vol 18
(3)
◽
pp. 258
◽